Literature DB >> 18792792

Effect of pH and formulation variables on in vitro transcorneal permeability of flurbiprofen: a technical note.

Sajeev Chandran1, Archna Roy, Ranendra N Saha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18792792      PMCID： PMC2977025          DOI： 10.1208/s12249-008-9139-4

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN： 1530-9932            Impact factor:   3.246


× No keyword cloud information.
  18 in total

1.  Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes.

Authors:  T F Patton; J R Robinson
Journal:  J Pharm Sci       Date:  1976-09       Impact factor: 3.534

2.  Electrophysiologic and morphologic effects of ophthalmic preparations on rabbit cornea epithelium.

Authors:  N L Burstein; S D Klyce
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-10       Impact factor: 4.799

3.  Morphology and histochemistry of the corneal epithelium of mammals.

Authors:  N Ehlers
Journal:  Acta Anat (Basel)       Date:  1970

4.  Effects of calcium chelating agents on corneal permeability.

Authors:  G M Grass; R W Wood; J R Robinson
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-01       Impact factor: 4.799

5.  Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.

Authors:  R D Schoenwald; H S Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

6.  Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops.

Authors:  Mahendra Singh Rathore; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2006-07-07       Impact factor: 3.246

7.  Effect of the ophthalmic preservative thimerosal on rabbit and human corneal endothelium.

Authors:  D L Van Horn; H F Edelhauser; G Prodanovich; R Eiferman; H F Pederson
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-04       Impact factor: 4.799

8.  An in vitro model for determination of drug permeability through the cornea.

Authors:  O Camber
Journal:  Acta Pharm Suec       Date:  1985

Review 9.  Species differences in the responses of the eye to irritation and trauma: a hypothesis of divergence in ocular defense mechanisms, and the choice of experimental animals for eye research.

Authors:  L Z Bito
Journal:  Exp Eye Res       Date:  1984-12       Impact factor: 3.467

10.  Ocular and systemic bioavailability of ophthalmic flurbiprofen.

Authors:  D D Tang-Liu; S S Liu; R J Weinkam
Journal:  J Pharmacokinet Biopharm       Date:  1984-12
View more
  5 in total

1.  Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin.

Authors:  María Sebastián-Morelló; María Aracely Calatayud-Pascual; Vicent Rodilla; Cristina Balaguer-Fernández; Alicia López-Castellano
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

2.  Enhancement in corneal permeability of riboflavin using calcium sequestering compounds.

Authors:  Peter W J Morrison; Vitaliy V Khutoryanskiy
Journal:  Int J Pharm       Date:  2014-06-10       Impact factor: 5.875

3.  Corneal Thickness Response after Anesthetic Eye Drops: Our Own Results and Meta-Analysis.

Authors:  Marcelino Perez-Bermejo; Alejandro Cervino; Ana M Calvo-Maroto; Monica Moscardo; Mayte Murillo-Llorente; Juan A Sanchis-Gimeno
Journal:  Biomed Res Int       Date:  2018-03-05       Impact factor: 3.411

4.  Ex-Vivo Trans-Corneal and Trans-Scleral Diffusion Studies with Ocular Formulations of Glutathione as an Antioxidant Treatment for Ocular Diseases.

Authors:  María Sebastián-Morelló; Adrián M Alambiaga-Caravaca; María Aracely Calatayud-Pascual; Vicent Rodilla; Cristina Balaguer-Fernández; María Miranda; Alicia López-Castellano
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

5.  Design of Targeted Flurbiprofen Biomimetic Nanoparticles for Management of Arthritis: In Vitro and In Vivo Appraisal.

Authors:  Hagar I Mohamed; Amal H El-Kamel; Ghada O Hammad; Lamia A Heikal
Journal:  Pharmaceutics       Date:  2022-01-07       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.